Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:35 pm Purchase |
2024-12-31 | 13G | ADC Therapeutics SA ADCT |
ORBIMED ADVISORS LLC | 3,437,813 3.600% |
3,437,813 (New Position) |
Filing History |
| 2025-02-03 6:10 pm Purchase |
2024-12-31 | 13G | ADC Therapeutics SA ADCT |
BLACKROCK INC BLK |
5,011,857 5.200% |
5,011,857 (New Position) |
Filing History |
| 2024-11-14 9:00 pm Purchase |
2024-09-30 | 13G | ADC Therapeutics SA ADCT |
Redmile Group LLC | 15,669,217 16.200% |
340,900 (+2.22%) |
Filing History |
| 2024-11-13 08:58 am Sale |
2024-09-30 | 13G | ADC Therapeutics SA ADCT |
Prosight Management LP | 9,617,531 9.950% |
-9,486 (-0.10%) |
Filing History |
| 2024-11-13 08:30 am Purchase |
2024-09-30 | 13G | ADC Therapeutics SA ADCT |
Prosight Management LP | 9,627,017 9.960% |
3,155,217 (+48.75%) |
Filing History |
| 2024-05-03 9:31 pm Purchase |
2024-04-25 | 13G | ADC Therapeutics SA ADCT |
Oaktree Capital Group Holdings GP LLC | 4,280,660 5.190% |
4,280,660 (New Position) |
Filing History |
| 2024-04-25 4:10 pm Sale |
2024-04-23 | 13D | ADC Therapeutics SA ADCT |
AUVEN THERAPEUTICS HOLDINGS LP | 2,255,719 2.700% |
-4,074,829 (-64.37%) |
Filing History |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | ADC Therapeutics SA ADCT |
Redmile Group LLC | 15,328,317 18.800% |
1,763,068 (+13.00%) |
Filing History |
| 2024-02-13 09:47 am Purchase |
2023-12-31 | 13G | ADC Therapeutics SA ADCT |
Prosight Management LP | 6,471,800 8.000% |
2,167,282 (+50.35%) |
Filing History |
| 2024-02-12 10:13 am Unchanged |
2023-12-31 | 13G | ADC Therapeutics SA ADCT |
ASTRAZENECA PLC | 4,011,215 4.880% |
0 (Unchanged) |
Filing History |
| 2023-04-28 4:08 pm Unchanged |
2023-04-27 | 13D | ADC Therapeutics SA ADCT |
AUVEN THERAPEUTICS HOLDINGS LP | 6,330,548 7.900% |
0 (Unchanged) |
Filing History |
| 2023-04-14 5:45 pm Purchase |
2023-04-06 | 13G | ADC Therapeutics SA ADCT |
Prosight Management LP | 4,304,518 5.300% |
4,304,518 (New Position) |
Filing History |
| 2023-04-10 09:37 am Sale |
2023-04-06 | 13G | ADC Therapeutics SA ADCT |
FMR CORP | 40,444 0.050% |
-4,613,009 (-99.13%) |
Filing History |
| 2023-02-10 5:18 pm Purchase |
2022-12-31 | 13G | ADC Therapeutics SA ADCT |
Redmile Group LLC | 13,565,249 16.800% |
6,114,220 (+82.06%) |
Filing History |
| 2023-02-09 08:23 am Sale |
2023-02-09 | 13G | ADC Therapeutics SA ADCT |
FMR CORP | 4,653,453 6.050% |
-3,019,220 (-39.35%) |
Filing History |
| 2023-02-06 2:56 pm Sale |
2023-02-02 | 13D | ADC Therapeutics SA ADCT |
AUVEN THERAPEUTICS HOLDINGS LP | 6,330,548 7.900% |
-12,000,000 (-65.46%) |
Filing History |
| 2022-12-22 7:30 pm Unchanged |
2022-12-22 | 13D | ADC Therapeutics SA ADCT |
AUVEN THERAPEUTICS HOLDINGS LP | 18,330,548 23.800% |
0 (Unchanged) |
Filing History |
| 2022-12-09 4:06 pm Sale |
2022-12-08 | 13D | ADC Therapeutics SA ADCT |
AUVEN THERAPEUTICS HOLDINGS LP | 18,330,548 23.800% |
-3,088,182 (-14.42%) |
Filing History |
| 2022-12-08 09:07 am Sale |
2022-12-08 | 13D | ADC Therapeutics SA ADCT |
AUVEN THERAPEUTICS HOLDINGS LP | 21,418,730 27.800% |
-775,000 (-3.49%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | ADC Therapeutics SA ADCT |
Redmile Group LLC | 7,451,029 9.700% |
692,235 (+10.24%) |
Filing History |